Laurens van Zandvoort

Showing 1-2 of 2 articles

Coronary interventions

Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study

van Zandvoort L, Dudek D, Weber-Albers J, Abizaid A, Christiansen E, Muller D, Kochman J, Kołtowski Ł, Lassen J, Wojdyla R, Wykrzykowska J, Onuma Y, Daemen J

December 7, 2018 | 10.4244/EIJ-D-18-00491

Interventions for hypertension

Serial quantitative magnetic resonance angiography follow-up of renal artery dimensions following treatment by four different renal denervation systems

van Zandvoort L, van Kranenburg M, Karanasos A, Van Mieghem N, Ouhlous M, van Geuns R, van Domburg R, Daemen J

April 7, 2017

1

Latest news

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

January 20, 2021

The Year in Review

M. Lunardi et al

January 22, 2021

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...

January 12, 2021

Valvular disease